AL

Arjula Lavanya

Director Director DIN 09293460
DIN 09293460 First appointment Aug 2021 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Aug 2021
Shareholding value Locked Premium profile

About Arjula Lavanya

Data last updated:

Arjula Lavanya has 5 years in corporate governance. Formerly with 1 company, such as Benzaiten Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 09293460
Primary Designation Director
First Appointment 26 Aug 2021
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Benzaiten Pharma Private Limited U24304TG2018PTC128561
Director26 Aug 20212018Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Benzaiten Pharma Private Limited
Premium access

Shareholding and investment profile for Arjula Lavanya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arjula Lavanya

Arjula Lavanya has 5 years in corporate governance. Formerly with 1 company, such as Benzaiten Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Arjula Lavanya is associated with 0 companies as a director.

Arjula Lavanya has expertise in General Business.

Arjula Lavanya has 5 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available